Application no. and date | 18192504.1 (espacenet) (Federated) (European Patent Register), 20131101 | Patent/reg. no. and date | DK/EP 3470063, 20250101 | Publication date | 20190417 | Priority no. and date | US 201261721622 P, 20121102, US 201261728328 P, 20121120, US 201361770668 P, 20130228, US 201361824005 P, 20130516, US 201361840668 P, 20130628 | EP pub. no. and date |
EP 3470063 20190417 | Effective date | | Applicant/owner | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | Applicant ref. no. | V485239DK00 | Inventor | VERWIJS, Marinus, Jacobus, 4 Carter Drive
Framingham, Massachusetts 01701, US, KARKARE, Radhika, 88 Oxbow Road
Framingham, Massachusetts 01701, US, MOORE, Michael, Douglas, 22 Prospect Street Unit 1
Charlestown, Massachusetts 02129, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/443 (2006.01) , A61K 31/47 (2006.01) , A61K 45/06 (2006.01) , A61K 9/20 (2006.01) , A61P 11/00 (2006.01) | Title | FARMACEUTISKE SAMMENSÆTNINGER TIL BEHANDLING AF CFTR-MEDIEREDE SYGDOMME | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|